Placental inflammation, oxidative stress, and fetal outcomes in maternal obesity
Using semaglutide after the expiry date increases the risk of infections, adverse reactions, and unexpected side effects
Semaglutide, in short, is a supplement for obese and overweight individuals who are already suffering from weight-related diseases, mainly type 2 diabetes
**No appetite suppression** Some users preferred a fat loss peptide that did not change their eating patterns 3
In an emailed statement to Newsday, pharmaceutical company Novo Nordisk, which manufactures drugs with semaglutide, said that "NAION is a very rare eye disease, and it is not an adverse drug reaction for the marketed formulations of semaglutide (Ozempic, Rybelsus and Wegovy) as per the approved labels in the U.S." The company said their own assessment of the data is that there is no proof that their drugs cause vision loss
Research suggests that mindful eating practices can lead to improved dietary habits and enhanced weight loss results
